Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States.
Cronos Group stock last closed at $1.77, up 1.72% from the previous day, and has decreased 25% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.31 percentage points. Cronos Group stock is currently +10.63% from its 52-week low of $1.60, and -43.63% from its 52-week high of $3.14.
As of Apr 22, 2025, there are 382.53M CRON shares outstanding. The market capitalization of CRON is $677.08M. In the last 24 hours, 1.14M CRON shares were traded.
How to Buy Cronos Group Stock
Wondering how to invest in Cronos Group stock? Here's how.
Choose where to buy Cronos Group stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Cronos Group stock.
Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Fund your investment account: Pick your method of payment and add your information.
Analyze Cronos Group stock: The Cronos Group ticker symbol is CRON. Is Cronos Group stock a good investment? Should you buy shares of CRON? How do CRON's underlying business fundamentals look? Do top analysts think Cronos Group is a good buy? Why has CRON's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if CRON is a good stock to buy).
Place your CRON trade: Decide if you will purchase CRON shares at the current market price or use a limit order to purchase CRON stock at a given price.
Keep an eye on your investment in CRON: Create a watchlist to track your position in Cronos Group shares.
Step 1: Choose where to buy Cronos Group stock
You need a brokerage account to access the NASDAQ market and buy CRON stock.
A brokerage account enables you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
We believe that eToro is the best online stock brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to global markets: From Tech to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've chosen your brokerage, the next step is to fill out some personal details so you can invest in CRON stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Cronos Group stock
After you have decided on the best place to buy Cronos Group stock, it's absolutely critical to evaluate their stock prior to buying, so you actually understand the risk and opportunity.
Overview of key CRON info
CRON Price
$1.77
1w %
2.91%
1y %
-25%
5y %
-70%
P/E
N/A
P/B
0.64x
P/S
5.77x
PEG
N/A
Revenue
$117.62M
Earnings
$41.08M
Fore. Rev. Growth
16.09%
Fore. Earn. Growth
N/A
Market Cap
$677.08M
Next Earnings
May 7, 2025
Next Dividend
N/A
CRON Due Diligence Score
WallStreetZen was designed to help everyday investors do better fundamental analysis in minutes instead of hours.
Last year, CRON revenue was $117.62M. Over the past five year, CRON's revenue has gone up by 37.71% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 7.84%.
Over the last year, executives and large shareholders at CRON have sold more shares than they have bought.
Michael Ryan Gorenstein, Chairman Chief Executive Officer and President of CRON, was the latest CRON insider to sell. They sold $2,148,510.00 worth of CRON stock on Mar 21, 2025.
No, Cronos Group doesn't provide an income stream by paying out dividends.
CRON Social Trading Data
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your CRON trade
There are two primary order types:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are usually sufficient.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at a specific dollar amount, place a limit order.
Hit the Open Trade button and your broker will execute the order.
If you require more help buying stocks on eToro, watch the how to video below:
How much does it cost to buy one Cronos Group share?
As of Apr 22, 2025, it costs $1.77 to buy one share of Cronos Group stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.89, you can buy 0.5 shares of CRON.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.